Enanta Pharmaceuticals
ENTA
ENTA
144 hedge funds and large institutions have $539M invested in Enanta Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
13% less capital invested
Capital invested by funds: $621M → $539M (-$81M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
144
Holding in Top 10
2
Calls
$654K
Puts
$734K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$16.9M | |
| 3 | +$11M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.61M |
| 5 |
HA
Hays Advisory
Franklin,
Tennessee
|
+$8.96M |
Top Sellers
| 1 | -$24.2M | |
| 2 | -$10.6M | |
| 3 | -$7.34M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$5.45M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$4.92M |